This is a Abbott news story, published by Investor's Business Daily, that relates primarily to Vijay Kumar news.
For more Abbott news, you can click here:
more Abbott newsFor more Vijay Kumar news, you can click here:
more Vijay Kumar newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Abbott stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diabetes business news, medical devices business news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Abbott LaboratoriesInvestor's Business Daily
•85% Informative
Abbott Laboratories ( ABT ) earned $ 1.14 a share on $10.38 billion in sales during the three months ended June 30 .
Earnings climbed nearly 6% year over year and topped analysts' call by three pennies.
The medical devices segment drove Abbott 's second-quarter beat, Evercore ISI analyst Vijay Kumar said.
VR Score
90
Informative language
94
Neutral language
60
Article tone
formal
Language
English
Language complexity
39
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links